Apr.Selected as an Export Voucher recipient company
provided by Korea Trade-Investment Promotion
Mar.Approved for NIH grant to support Exosome-based
Mar.Relocated corp. building to Daedeok Techno valley,
Jan.Established ILIAS Therapeutics, Inc. in New York, US.
May.Series A Funding (KRW 18.3 billion).
Nov.Approved for Institut Pasteur Korea occupancy.
Oct.Approved for Seoul BioHub occupancy.
Sept.2nd Angel Funding.
May.Acquired a K-Healthcare Start-up membership
by Korean Health Industry Development Institute.
Feb.1st Angel Funding.
Jan.Certified as Venture company.
Nov.Approved as a venture company with research facilities.
Nov.Established corp. in Daejeon, Korea.